{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:25:37Z","timestamp":1794119137635,"version":"4.8.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1309\/ajcp8g5rmtwuemuu","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T23:41:55Z","timestamp":1258587715000},"page":"940-949","source":"Crossref","is-referenced-by-count":81,"title":["Characterization of Immunophenotypic Aberrancies in 200 Cases of B Acute Lymphoblastic Leukemia"],"prefix":"10.1093","volume":"132","author":[{"given":"Adam C.","family":"Seegmiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Kroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin J.","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,1]]},"reference":[{"key":"2016010322464408000_132.6.940.1","unstructured":"Borowitz MJ Chan JKC . B lymphoblastic leukaemia\/lymphoma, not otherwise specified. In: Swerdlow SH Campo E Harris NL , eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:168\u2013170. WHO Classification of Tumours; vol 2."},{"key":"2016010322464408000_132.6.940.2","doi-asserted-by":"crossref","unstructured":"Muehleck SD McKenna RW Gale PF Terminal deoxynucleotidyl transferase (TdT)-positive cells in bone marrow in the absence of hematologic malignancy. Am J Clin Pathol. 1983;79:277\u2013284.","DOI":"10.1093\/ajcp\/79.3.277"},{"key":"2016010322464408000_132.6.940.3","doi-asserted-by":"crossref","unstructured":"Caldwell CW Poje E Helikson MA . B-cell precursors in normal pediatric bone marrow. Am J Clin Pathol. 1991;95:816\u2013823.","DOI":"10.1093\/ajcp\/95.6.816"},{"key":"2016010322464408000_132.6.940.4","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199302000-00007"},{"key":"2016010322464408000_132.6.940.5","doi-asserted-by":"crossref","unstructured":"Vandersteenhoven AM Williams JE Borowitz MJ . Marrow B-cell precursors are increased in lymphomas or systemic diseases associated with B-cell dysfunction. Am J Clin Pathol. 1993;100:60\u201366.","DOI":"10.1093\/ajcp\/100.1.60"},{"key":"2016010322464408000_132.6.940.6","doi-asserted-by":"crossref","unstructured":"Davis RE Longacre TA Cornbleet PJ . Hematogones in the bone marrow of adults: immunophenotypic features, clinical settings, and differential diagnosis. Am J Clin Pathol. 1994;102:202\u2013211.","DOI":"10.1093\/ajcp\/102.2.202"},{"key":"2016010322464408000_132.6.940.7","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.1147"},{"key":"2016010322464408000_132.6.940.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.8.2498"},{"key":"2016010322464408000_132.6.940.9","doi-asserted-by":"publisher","DOI":"10.1159\/000079907"},{"key":"2016010322464408000_132.6.940.10","unstructured":"Guiziry DE El GW Farahat N Phenotypic analysis of bone marrow lymphocytes from children with acute thrombocytopenic purpura. Egypt J Immunol. 2005;12:9\u201314."},{"key":"2016010322464408000_132.6.940.11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20986"},{"key":"2016010322464408000_132.6.940.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.06.023"},{"key":"2016010322464408000_132.6.940.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05011.x"},{"key":"2016010322464408000_132.6.940.14","unstructured":"Schuurmans Stekhoven JH Langenhuysen CA Bakkeren JA Morphology and incidence of the \u201cposttherapeutic lymphoid cell\u201d in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 1986;124:46\u201352."},{"key":"2016010322464408000_132.6.940.15","doi-asserted-by":"crossref","unstructured":"Kobayashi SD Seki K Suwa N The transient appearance of small blastoid cells in the marrow after bone marrow transplantation. Am J Clin Pathol. 1991;96:191\u2013195.","DOI":"10.1093\/ajcp\/96.2.191"},{"key":"2016010322464408000_132.6.940.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00282-997-0139-8"},{"key":"2016010322464408000_132.6.940.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02143.x"},{"key":"2016010322464408000_132.6.940.18","doi-asserted-by":"crossref","unstructured":"Weir EG Cowan K LeBeau P A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection. Leukemia. 2001;13:558\u2013567.","DOI":"10.1038\/sj.leu.2401364"},{"key":"2016010322464408000_132.6.940.19","doi-asserted-by":"publisher","DOI":"10.1080\/1042819031000151950"},{"key":"2016010322464408000_132.6.940.20","doi-asserted-by":"crossref","unstructured":"Hurwitz CA Loken MR Graham ML Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood. 1988;72:299\u2013307.","DOI":"10.1182\/blood.V72.1.299.bloodjournal721299"},{"key":"2016010322464408000_132.6.940.21","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910615)67:12<3081::AID-CNCR2820671224>3.0.CO;2-Y"},{"key":"2016010322464408000_132.6.940.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01300.x"},{"key":"2016010322464408000_132.6.940.23","doi-asserted-by":"crossref","unstructured":"Khalidi HS Chang KL Medeiros LJ Acute lymphoblastic leukemia: survey of immunophenotype, French-American-British classification, frequency of myeloid antigen expression, and karyotypic abnormalities in 210 pediatric and adult cases. Am J Clin Pathol. 1999;111:467\u2013476.","DOI":"10.1093\/ajcp\/111.4.467"},{"key":"2016010322464408000_132.6.940.24","doi-asserted-by":"publisher","DOI":"10.1309\/7R6MU7R9YWJBY5V4"},{"key":"2016010322464408000_132.6.940.25","doi-asserted-by":"publisher","DOI":"10.1309\/XREF-C9T2-6U0A-4EDT"},{"key":"2016010322464408000_132.6.940.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2004.05.006"},{"key":"2016010322464408000_132.6.940.27","unstructured":"Borowitz MJ Chan JKC . B lymphoblastic leukaemia\/lymphoma with recurrent cytogenetic abnormalities. In: Swerdlow SH Campo E Harris NL , eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:171\u2013175. WHO Classification of Tumours; vol 2."},{"key":"2016010322464408000_132.6.940.28","unstructured":"Bene MC Castoldi G Knapp W Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9:1783\u20131786."},{"key":"2016010322464408000_132.6.940.29","unstructured":"Borowitz MJ Bene M-C Harris NL Acute leukaemias of ambiguous lineage. In: Swerdlow SH Campo E Harris NL , eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:150\u2013155. WHO Classification of Tumours; vol 2."},{"key":"2016010322464408000_132.6.940.30","doi-asserted-by":"crossref","unstructured":"Borowitz MJ Hunger SP Carroll AJ Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implication for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. Blood. 1993;82:1086\u20131091.","DOI":"10.1182\/blood.V82.4.1086.bloodjournal8241086"},{"key":"2016010322464408000_132.6.940.31","doi-asserted-by":"crossref","unstructured":"Behm FG Raimondi SC Schell MJ Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features. Blood. 1992;79:1011\u20131016.","DOI":"10.1182\/blood.V79.4.1011.1011"},{"key":"2016010322464408000_132.6.940.32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402504"},{"key":"2016010322464408000_132.6.940.33","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.3603174.x"},{"key":"2016010322464408000_132.6.940.34","doi-asserted-by":"publisher","DOI":"10.1309\/LXU4-Q7Q9-3YAB-4QE0"},{"key":"2016010322464408000_132.6.940.35","doi-asserted-by":"publisher","DOI":"10.1159\/000077554"},{"key":"2016010322464408000_132.6.940.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2007.05.005"},{"key":"2016010322464408000_132.6.940.37","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2861"},{"key":"2016010322464408000_132.6.940.38","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050424"},{"key":"2016010322464408000_132.6.940.39","doi-asserted-by":"crossref","unstructured":"Pui CH Rubnitz JE Hancock ML Reappraisal of the clinical and biologic significance of myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol. 1998;16:3768\u20133773.","DOI":"10.1200\/JCO.1998.16.12.3768"},{"key":"2016010322464408000_132.6.940.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2007.02.004"},{"key":"2016010322464408000_132.6.940.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2007.08.012"},{"key":"2016010322464408000_132.6.940.42","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10385"},{"key":"2016010322464408000_132.6.940.43","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109099329"},{"key":"2016010322464408000_132.6.940.44","unstructured":"Brunning RD Matutes E Borowitz M Acute leukaemias of ambiguous lineage. In: Jaffe ES Harris NL Stein H , eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. 3rd ed. Lyon, France: IARC Press; 2001:106\u2013107. World Health Organization Classification of Tumours."},{"key":"2016010322464408000_132.6.940.45","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00523.x"},{"key":"2016010322464408000_132.6.940.46","unstructured":"Killick S Matutes E Powles RL Outcome of acute biphenotypic leukemia. Haematologica. 1999;84:699\u2013706."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/132\/6\/940\/4993259\/ajcpath132-0940.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T15:31:45Z","timestamp":1590247905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/AJCP8G5RMTWUEMUU"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,12,1]]},"published-print":{"date-parts":[[2009,12]]}},"alternative-id":["10.1309\/AJCP8G5RMTWUEMUU"],"URL":"https:\/\/doi.org\/10.1309\/ajcp8g5rmtwuemuu","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}